147 related articles for article (PubMed ID: 21174222)
1. Contribution of rural-to-urban migration in the prevalence of drug resistant tuberculosis in China.
Wang W; Wang J; Zhao Q; Darling ND; Yu M; Zhou B; Xu B
Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):581-6. PubMed ID: 21174222
[TBL] [Abstract][Full Text] [Related]
2. Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors.
Shen X; DeRiemer K; Yuan ZA; Shen M; Xia Z; Gui X; Wang L; Gao Q; Mei J
Int J Tuberc Lung Dis; 2009 Feb; 13(2):253-9. PubMed ID: 19146756
[TBL] [Abstract][Full Text] [Related]
3. Proportions and Risk Factors of Developing Multidrug Resistance Among Patients with Tuberculosis in China: A Population-Based Case-Control Study.
Huai P; Huang X; Cheng J; Zhang C; Wang K; Wang X; Yang L; Deng Z; Ma W
Microb Drug Resist; 2016 Dec; 22(8):717-726. PubMed ID: 27058017
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
Che Y; Bo D; Lin X; Chen T; He T; Lin Y
BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
[TBL] [Abstract][Full Text] [Related]
6. Drug Resistance Characteristics of
Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
[No Abstract] [Full Text] [Related]
7. Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area.
Cucunawangsih ; Wiwing V; Widysanto A; Lugito NP
Int J Mycobacteriol; 2015 Dec; 4(4):302-5. PubMed ID: 26964812
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Multi-Drug Resistant
Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F
Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294
[TBL] [Abstract][Full Text] [Related]
10. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y
BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878
[TBL] [Abstract][Full Text] [Related]
11. SHORT COMMUNICATION-Pattern of anti-tuberculosis drugs susceptibility in new and previously treated tuberculosis patients and environmental risk factors investigation.
Hameed S; Mahmood N; Chaudhry MN; Ahmad SR; Aqeel Ur Rahman M; Hameed S; Mahmood N
Pak J Pharm Sci; 2019 Jul; 32(4):1709-1714. PubMed ID: 31608894
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
14. High incidence of drug-resistant Mycobacterium tuberculosis in Hainan Island, China.
Lin M; Zhong Y; Chen Z; Lin C; Pei H; Shu W; Pang Y
Trop Med Int Health; 2019 Sep; 24(9):1098-1103. PubMed ID: 31278806
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
17. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018.
Song WM; Li YF; Ma XB; Liu JY; Tao NN; Liu Y; Zhang QY; Xu TT; Li SJ; Yu CB; Gao L; Cui LL; Li HC
Respir Res; 2019 Oct; 20(1):223. PubMed ID: 31627757
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
Lu Z; Jiang W; Zhang J; Lynn HS; Chen Y; Zhang S; Ma Z; Geng P; Guo X; Zhang H; Zhang Z
PLoS One; 2019; 14(11):e0225361. PubMed ID: 31751390
[TBL] [Abstract][Full Text] [Related]
19. Migrations do not modify Mycobacterium tuberculosis resistance rates: a 20-year retrospective study.
Seminari E; Monzillo V; Lombardi A; Barbarini D; Scudeller L; Schimmenti A; Muzzi A; Marone P
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1083-1087. PubMed ID: 31980988
[TBL] [Abstract][Full Text] [Related]
20. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
Liu Z; Dong H; Wu B; Zhang M; Zhu Y; Pang Y; Wang X
J Infect; 2019 Oct; 79(4):349-356. PubMed ID: 31400354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
